ArticlePloS one2013

Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity.

Xiaofeng Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.